脂肪酸结合蛋白7 (FABP7) 在癌症中的新兴作用
William George Warren1, Myles Osborn1, Andrew Yates1
1Artelo Biosciences Limited, Alderley Park, Cheshire, UK.
Drug discovery today
|April 13, 2024
概括
脂肪酸结合蛋白7 (FABP7) 通过促进细胞生长,迁移和脂质代谢来推动癌症的进展. 抑制FABP7显著抑制瘤的形成和生长,为癌症治疗提供了一个有前途的治疗标.
科学领域:
- 生物化学 生化学
- 分子生物学分子生物学
- 在瘤学瘤学.
背景情况:
- 脂肪酸结合蛋白7 (FABP7) 是一种细胞内蛋白调节脂肪酸 (FA) 代谢.
- 在各种癌症中,FABP7的调节显著上升,与患者预后不佳相关.
研究的目的:
- 研究FABP7在癌症进展中的作用.
- 探索FABP7作为瘤学中的潜在治疗点.
主要方法:
- FABP7基因沉默和药物抑制.
- 细胞测试评估的增殖,迁移,入侵和脂质代谢.
- 在小鼠模型中进行异种移植研究.
主要成果:
- FABP7促进癌细胞的生长,迁移,入侵和脂质滴滴的形成.
- 抑制FABP7可以抑制瘤的形成和生长,并改善宿主生存率.
- FABP7影响关键的瘤信号通路,包括FAK,Src,MEK/ERK,Wnt/β-catenin,Hif1α,VEGFA/P4HA1,Snail1和Twist1.1,这些信号通路包括FAK,Src,MEK/ERK,Wnt/β-catenin,Hif1α,VEGFA/P4HA1,Snail1和Twist1.1,这些信号通路包括FAK,Src,MEK/ERK,Wnt/β-catenin,Hif1α,VEGFA/P4HA1,Snail1和Twist1.1.
结论:
- FABP7具有显著的致癌性质.
- 向FABP7代表了癌症治疗的有前途的治疗策略.
相关概念视频
03:03mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
01:32Lipids as Anchors
5.6K
In the plasma membrane, the lipids forming the bilayer can also act as an anchor to tether proteins to the membrane. The three main types of lipid anchors found in eukaryotes are – prenyl groups, fatty acyl groups, and glycosylphosphatidylinositol or GPI groups. Prenyl and fatty acyl groups act as anchors on the cytosolic surface of the membrane, whereas GPI anchors proteins on the extracellular side.
The carboxy-terminal of most of the prenylated proteins, such as Ras proteins, contains...
The carboxy-terminal of most of the prenylated proteins, such as Ras proteins, contains...
5.6K